<p>Data are n (%) or median (interquartile range). Baseline characteristics were at the date of diagnosis of interstitial lung disease and idiopathic lung fibrosis. The nested 1:2 matched study was matched on sex, diagnostic code (idiopathic lung fibrosis versus other), age at diagnosis, and year of diagnosis. Only interstitial lung disease/ idiopathic lung fibrosis patients using statins with two exact matching controls were included. Any interstitial lung disease treatment (azathioprine, N-acetylcystein, colchicine, systemic corticosteroids, cyclophosphamide, methotrexat, thalidomide, and mycophenolate) and chronic obstructive pulmonary disease treatment (beta2-adrenergic agonists, anticholinergic medication, theophylline, and inhaled glu...
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased...
Introduction PROOF (a Prospective Observational Registry to Describe the Disease Course and Outcomes...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...
Background and Objectives: This single-center retrospective study was conducted to describe clinical...
International audienceIn patients with chronic fibrosing interstitial lung disease (ILD), a progress...
PROOF (a Prospective Observational Registry to Describe the Disease Course and Outcomes of Idiopathi...
© Copyright ERS 2017. The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a rare life-threating interstitial lung d...
The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is esti...
The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is esti...
International audienceRationale: Idiopathic pulmonary fibrosis (IPF) is a rare condition and few epi...
Rationale: In recent decades, diagnosis and treatment recommendations for idiopathic pulmonary fibro...
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased...
Introduction PROOF (a Prospective Observational Registry to Describe the Disease Course and Outcomes...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...
Background and Objectives: This single-center retrospective study was conducted to describe clinical...
International audienceIn patients with chronic fibrosing interstitial lung disease (ILD), a progress...
PROOF (a Prospective Observational Registry to Describe the Disease Course and Outcomes of Idiopathi...
© Copyright ERS 2017. The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a rare life-threating interstitial lung d...
The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is esti...
The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is esti...
International audienceRationale: Idiopathic pulmonary fibrosis (IPF) is a rare condition and few epi...
Rationale: In recent decades, diagnosis and treatment recommendations for idiopathic pulmonary fibro...
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased...
Introduction PROOF (a Prospective Observational Registry to Describe the Disease Course and Outcomes...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...